Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving virus or bacteriophage
Reexamination Certificate
2008-07-01
2008-07-01
Chen, Stacy B. (Department: 1648)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving virus or bacteriophage
C424S208100
Reexamination Certificate
active
11053290
ABSTRACT:
Compositions are provided which include biodegradable microparticles with entrapped or adsorbed antigens, in combination with submicron oil-in-water emulsions. Also provided are methods of immunization which comprise administering to a vertebrate subject (a) a submicron oil-in-water emulsion, and (b) a therapeutically effective amount of a selected antigen entrapped in a microparticle.
REFERENCES:
patent: 5629167 (1997-05-01), Ratti
patent: 5783567 (1998-07-01), Hedley et al.
patent: 5869103 (1999-02-01), Yeh et al.
patent: 5961970 (1999-10-01), Lowell et al.
patent: 6086901 (2000-07-01), O'Hagan et al.
patent: 6306405 (2001-10-01), O'Hagan et al.
patent: 6458370 (2002-10-01), O'Hagan et al.
patent: 0 399 843 (1994-07-01), None
patent: WO 90/14837 (1990-12-01), None
patent: WO 92/00081 (1992-01-01), None
patent: WO 95/11010 (1995-04-01), None
patent: WO 95/28487 (1995-10-01), None
patent: WO 97/02810 (1997-01-01), None
Esparza et al., “Parameters Affecting the Immunogenicity of Microencapsulated Tetanus Toxid,” Vaccines 10(10):714-720 (1992).
Fahey et al., Status of Immune-Based Therapies in HIV Infection and AIDS, Clin. Exp. Immunol. vol. 88, pp. 1-5, 1992.
A.S. Fauci, “Update on the Status of Vaccine Development,” Pediatric Aids and HIV Infection: Fetus to Adolescent 5(1):47-58 (1994).
Fox, No Winners Against AIDS, Bio/Technology, vol. 12, p. 128, Feb. 1994.
Haynes et al., Update on the Issues of HIV Vaccine Development, The Finnish Medical Society, DUOCECIM, Ann. Med., vol. 28, pp. 39-41, 1996.
Higgins et al., “MF59 Adjuvant Enhances the Immunogenicity of Influenza Vaccine in Both Young and Old Mice,” Vaccine 14(6):478-484 (1996).
Moore et al., “Immunization with a Soluble Recombinant HIV Protein Entrapped in Biodegradable Microparticles Induces HIV-Specific CD8+ Cytotoxic T Lymphocytes and CD4+ Th1 Cells,” Vaccine 13(18):1741-1749 (1995).
O'Hagan et al., “Biodegradable Microparticles for Oral Immunization,” Vaccine 11:149-154 (1993).
O'Hagan, “Recent Advances in Vaccine Adjuvant for Systemic and Mucosal Administration,” J. Pharm. Pharmacol 49:1-10 (1997).
Ott et al., “MF59—Design and Evaluation of a Safe and Potent Adjuvant for Human Vaccines,” Vaccine Design: The Subunit and Adjuvant Approach (Powell, M.F. and Newman, M.J. eds.) Plenum Press, New York, pp. 277-296 (1995).
Sanchez-Pescador et al., “The Effect of Adjuvants on the Efficacy of a Recombinant Herpes Simplex Virus Glycoprotein Vaccine,” The Journal of Immunol. 141(5):1720-1727 (1988).
Vordermeier et al., “Synthetic Delivery System for Tuberculosis Vaccines: Immunological Evaluation of the M. Tuberculosis 38 kDa Protein Entrapped in Biodegradable PLG Microparticles,” Vaccine 13(16):1576-1582 (1995).
O'Hagan Derek
Ott Gary S.
Singh Manmohan
Van Nest Gary
Chen Stacy B.
Lee Helen
Novartis Vaccines and Diagnostics Inc.
Robins Roberta L.
LandOfFree
Use of microparticles combined with submicron oil-in-water... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of microparticles combined with submicron oil-in-water..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of microparticles combined with submicron oil-in-water... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3941974